focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarshalls Regulatory News (MSLH)

Share Price Information for Marshalls (MSLH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 314.00
Bid: 313.00
Ask: 314.50
Change: 1.00 (0.32%)
Spread: 1.50 (0.479%)
Open: 316.00
High: 316.00
Low: 306.50
Prev. Close: 313.00
MSLH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Statement

13 May 2020 07:00

RNS Number : 6900M
Marshalls PLC
13 May 2020
 

 

LEI: 213800S21IFC367J5V62

 

 

Trading Update: 13 May 2020

 

Ahead of its Annual General Meeting at 11.00am today, Marshalls plc, the specialist landscape products group, issues a Trading Update and further information on the measures it is taking in response to the COVID-19 outbreak.

 

COVID-19 update

 

Marshalls continues to monitor the impact that COVID-19 is having on the business and the wider industry. Our priority is to ensure the safety and well-being of our employees, suppliers and customers at this time. In line with our sector, we have seen a sharp drop in demand. As previously advised, actions have been, and continue to be, taken to control costs and maintain our cash liquidity. As part of these actions, the Board and Executive management have agreed to a 20 per cent reduction in remuneration. Senior managers in the business have now also agreed a 15 per cent reduction in their remuneration. Additionally, we are utilising the Government's scheme which allows the deferral of tax payments that would normally have been payable in the period to 30 June 2020. We also continue to utilise the furlough arrangements that are in place.

 

We have now taken further steps to restructure the Group's operations. We have entered into consultations with employees across the Group as part of a series of restructuring proposals that cover all parts the business. These proposals include selective site closures, changes in shift patterns and proposed changes to the size of and structure of support functions. There are potentially up to 400 positions representing 15 per cent of Marshalls total workforce, that may be impacted as a result of these proposed changes. We are reopening our plants as demand returns. The nature of the concrete manufacturing process means our facilities have low re-start time and cost requirements. This flexibility and our improved efficiency means that capacity will not be materially reduced by the proposed changes and we will continue to satisfy our customers' requirements.

 

We are taking all appropriate steps to support the long-term interests of the business, its employees and other stakeholders.

 

Bank Facilities

 

Further to the announcement on 14 April 2020, the Group has now signed final agreements with each of NatWest, Lloyds and HSBC for an additional £30 million, 12 month committed revolving credit facility with each, with a 12-month extension option. These additional facilities comprise £90 million and significantly strengthen the Group's headroom. Including these additional facilities, Marshalls now has total bank facilities of £255 million of which £230 million are committed. As at 30 April the Group had net debt of £69 million, on a pre-IFRS 16 basis.

 

In addition, Marshalls plc has been confirmed as being eligible for the Covid Corporate Financing Facility ("CCFF") with an issuer limit of £200 million. We have now completed the processes and documentation to establish a commercial paper programme under this scheme and are able to access the liquidity available to us under this facility.

 

The Board considers that the facilities now available to the Group, both from its enhanced bank facilities and its CCFF commercial paper programme, are sufficient to meet significant downside liquidity scenarios over a prolonged period.

 

Trading performance

 

As a result of the impact of the COVID-19 crisis, sales in the first four months through to 30 April were down 27 per cent at £131 million (2019: £180 million). Sales activity took a steep drop in the last week of March and throughout April. However, In the early part of May we have seen daily levels of activity progressively improve and we are currently at circa 50 per cent of our daily revenues compared to the same period in 2019.

 

Outlook

 

Our operational planning continues to be dynamic and capable of reacting to the changing environment. We are closely monitoring cash flows to ensure that the business is in a strong position for eventual recovery. Our priority is to ensure the health and safety of our employees, and consequently detailed additional safety standards and procedures have been put in place, which are in line with current Government COVID-19 guidance, to allow our sites to operate safely. We will meet the demands of our stakeholders and protect the long term sustainability of the business.

 

The combined effect of the cost reductions, the restructuring programme and the new bank facilities will leave the Group stronger and well placed to meet the current challenges and also well positioned for eventual future opportunities.

 

At this time, it does not remain possible for the Group to provide an accurate assessment of trading for the current year and accordingly all previous market guidance continues to be withdrawn.

 

Certain information contained in this announcement would have constituted inside information (as defined by Article 7 of Regulation (EU) No 596/2014) ("MAR") prior to its release as part of this announcement and is disclosed in accordance with the Company's obligations under Article 17 of those Regulations.

 

Enquiries:

Martyn Coffey

Chief Executive

Marshalls plc

+44 (0)1422 314777

Jack Clarke

Group Finance Director

 

Marshalls plc

+44 (0)1422 314777

Andrew Jaques

 

MHP Communications

+44 (0)20 3128 8540

Charlie Barker

 

 

 

 

Note to the Editor:

 

About Marshalls:

 

Established in the late 1880s, Marshalls is the UK's leading manufacturer of superior natural stone and innovative concrete hard landscaping products, supplying the construction, home improvement and landscape markets. Marshalls provides the product ranges, design services, technical expertise, innovative ideas and inspiration to transform gardens, drives and public and commercial landscapes.

 

Marshalls operates its own quarries and manufacturing sites throughout the UK, including a national network of manufacturing and distribution sites, and has operations in Belgium and sales representation in other international markets. As a major plc, Marshalls is committed to quality in everything it does, including the achievement of high environmental and ethical standards and continual improvement in health and safety performance.

 

Forward-Looking Statements:

 

Any statements in this release, to the extent that they are forward-looking, are subject to risk factors associated with, amongst other things, the economic and business circumstances occurring from time to time in the markets in which Marshalls operates. It is believed that the expectations reflected in these statements are reasonable but they may be affected by a wide range of variables which could cause actual results to differ materially from those currently anticipated. More information about the factors that may affect Marshalls' performance is contained in the Annual Report to shareholders for the year ended 31 December 2019.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTATMFTMTBBBJM
Date   Source Headline
15th May 20241:01 pmRNSResult of AGM
15th May 20247:00 amRNSTrading Statement
29th Apr 20243:25 pmRNSDirector/PDMR Shareholding - Correction
29th Apr 202411:45 amRNSDirector/PDMR Shareholding
19th Apr 20248:51 amRNSHolding(s) in Company
10th Apr 20242:03 pmRNSAnnual Financial Report
22nd Mar 202412:40 pmRNSDirector/PDMR Shareholding
19th Mar 20242:00 pmRNSDirector/PDMR Shareholding
19th Mar 20241:59 pmRNSDirector/PDMR Shareholding
19th Mar 20241:57 pmRNSDirector/PDMR Shareholding
19th Mar 20241:56 pmRNSDirector/PDMR Shareholding
18th Mar 202412:07 pmRNSDirector/PDMR Shareholding
18th Mar 20247:00 amRNSFinal Results
26th Feb 202410:36 amRNSDirector/PDMR Shareholding
15th Feb 20249:49 amRNSHolding(s) in Company
1st Feb 202411:59 amRNSHolding(s) in Company
31st Jan 20241:17 pmRNSHolding(s) in Company
18th Jan 20247:00 amRNSTrading Statement
21st Dec 20239:36 amRNSHolding(s) in Company
6th Dec 20237:00 amRNSCEO Succession
1st Dec 20233:08 pmRNSHolding(s) in Company
28th Nov 20233:17 pmRNSHolding(s) in Company
7th Nov 20231:47 pmRNSStatement re 2023 AGM Remuneration Report Vote
3rd Nov 202310:38 amRNSDirector Declaration
27th Oct 20239:56 amRNSHolding(s) in Company
23rd Oct 20234:14 pmRNSHolding(s) in Company
20th Oct 202310:36 amRNSHolding(s) in Company
18th Oct 20234:04 pmRNSHolding(s) in Company
18th Oct 20234:02 pmRNSHolding(s) in Company
18th Oct 202312:38 pmRNSDirector/PDMR Shareholding
18th Oct 20237:00 amRNSTrading Statement
17th Oct 202311:52 amRNSHolding(s) in Company
6th Oct 20233:39 pmRNSHolding(s) in Company
4th Oct 20233:41 pmRNSDirector/PDMR Shareholding
2nd Oct 20231:08 pmRNSHolding(s) in Company
17th Aug 20237:00 amRNSDirector/PDMR Shareholding
17th Aug 20237:00 amRNSDirector/PDMR Shareholding
16th Aug 20237:00 amRNSHalf-year Report
2nd Aug 20238:49 amRNSHolding(s) in Company
31st Jul 20237:00 amRNSTrading Statement
21st Jul 202311:25 amRNSDirector Declaration
19th Jul 202312:09 pmRNSDirector Declaration
13th Jul 20234:44 pmRNSDirector/PDMR Shareholding
13th Jul 20234:42 pmRNSDirector/PDMR Shareholding
13th Jul 20234:40 pmRNSDirector/PDMR Shareholding
26th Jun 20234:45 pmRNSDirector/PDMR Shareholding
26th Jun 20234:42 pmRNSDirector/PDMR Shareholding
21st Jun 20232:13 pmRNSHolding(s) in Company
25th May 20233:05 pmRNSHolding(s) in Company
12th May 20239:13 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.